Anti-influenza drugs

Development of new drugs against influenza has been of great interest. Number of drugs show Anti-influenza properties, but may have altered effects for the use in clinic. These drugs target viral components and some target the host cell elements which help in the viral cycle, but related side effects are the disadvantages. As for now, four antiviral drugs have been discovered against influenza; zanamivir and oseltamivir which inhibit neuraminidase which act in both Influenza A and Influenza B, while rimantadine and amantadine block M2 passage of influenza A.


When a new variety of influenza virus transmits rapidly it may lead to pandemic. Even the drugs may possibly show no effects to same degree. Government maintains a stock of these drugs to use during pandemics. According to FDA three drugs are present which can be used during circulating viruses; Rapivab, Relenza, Tamiflu (oseltamivir which is generic)


  • Clinical trials
  • Influenza and pneumonia
  • Influenza immunization
  • Ethical preparedness

Related Conference of Anti-influenza drugs

September 23-24, 2019

11th Euro-Global Conference on Infectious Diseases

London, UK

Venue: Park Inn by Radisson Hotel & Conference Centre London Heathrow
September 23-24, 2019

8th International Conference on Tropical Medicine and Infectious Diseases

| ANA Crowne Plaza, Narita | Tokyo, Japan
October 07-08, 2019

5th Annual Congress on Infectious Diseases

Frankfurt, Germany
October 21-22, 2019

15th World Congress on Infection Prevention and Control


Venue: Mövenpick Hotel Zürich Airport
November 25-26, 2019

2nd World Congress on Rare Diseases

Dubai, UAE
January 27-28, 2020

3rd Global Experts Meeting on Infectious Diseases

| Bangkok, Thailand
Feb 24-25, 2020

7th International Congress on Infectious Diseases

Berlin, Germany
March 11-12, 2020

8th International Conference on HIV AIDS STD & STIs

Barcelona, Spain
May 18-19, 2020

7th Global Congress on Rare Diseases & Orphan Drug

Istanbul, Turkey
July 22-23, 2020

10th World Congress on Rare Diseases and Orphan Drugs

Barcelona, Spain
December 06-07, 2021

3rd World Congress on Rare Diseases

Dubai, UAE

Anti-influenza drugs Conference Speakers

Recommended Sessions

Related Journals

Are you interested in